{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:23:42Z","timestamp":1790623422734,"version":"4.1.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR\u2014M4C2-I1.3 Project PE_00000019 \u201cHEAL ITALIA\u201d"],"award-info":[{"award-number":["PNRR\u2014M4C2-I1.3 Project PE_00000019 \u201cHEAL ITALIA\u201d"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["CUP I53C22001440006"],"award-info":[{"award-number":["CUP I53C22001440006"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR-MR1-2022-12376879"],"award-info":[{"award-number":["PNRR-MR1-2022-12376879"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN-PNRR 2022 \u201cEXTREMEHEART\u201d - CUP J53D23003350006"],"award-info":[{"award-number":["PRIN-PNRR 2022 \u201cEXTREMEHEART\u201d - CUP J53D23003350006"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02095-0","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T19:33:07Z","timestamp":1768246387000},"page":"2243-2266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Circulating microRNAs in pulmonary arterial hypertension: biomarkers for diagnosis, prognostic stratification, and treatment"],"prefix":"10.1007","volume":"48","author":[{"given":"Beatrice","family":"Polini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ghelardoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerarda","family":"Capone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Chiellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"2095_CR1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.01913-2018.","journal-title":"Eur Respir J"},{"key":"2095_CR2","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1177\/02692155221121006","volume":"36","author":"L Crawford","year":"2022","unstructured":"Crawford L, Maxwell J, Colquhoun H, Kingsnorth S, Fehlings D, Zarshenas S, et al. Facilitators and barriers to patient-centred goal-setting in rehabilitation: a scoping review. Clin Rehabil. 2022;36:1694\u2013704. https:\/\/doi.org\/10.1177\/02692155221121006.","journal-title":"Clin Rehabil"},{"key":"2095_CR3","doi-asserted-by":"publisher","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS,\u00a0 Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E,\u00a0 Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, R\u00e5degran G, Simonneau G, Sitbon O,\u00a0 Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S, Schwerzmann M, Dinh-Xuan AT, Bush A, Abdelhamid M, Aboyans V, Arbustini E, Asteggiano R, Barber\u00e0 JA, Beghetti M, \u010celutkien\u0117 J,\u00a0 Cikes M, Condliffe R,\u00a0 de Man F, Falk V, Fauchier L, Gaine S, Gali\u00e9 N, Gin-Sing W, Granton J, Gr\u00fcnig E, Hassoun PM, Hellemons M,\u00a0 Jaarsma T, Kjellstr\u00f6m B, Klok FA, Konradi A,\u00a0 Koskinas KC, Kotecha D, Lang I, Lewis BS, Linhart A,\u00a0 Lip GYH, L\u00f8chen ML,\u00a0 Mathioudakis AG,\u00a0 Mindham R, Moledina S, Naeije R, Nielsen JC, Olschewski H, Opitz I, Petersen SE,\u00a0 Prescott E,\u00a0 Rakisheva A,\u00a0 Reis A,\u00a0 Risti\u0107 AD, Roche N, Rodrigues R, Selton-Suty C, Souza R,\u00a0 Swift AJ,\u00a0 Touyz RM,S. Ulrich S, Wilkins MR, Wort SJ, Krim M, Hayrapetyan H,\u00a0 Musayev O, Lazareva I, Sokolovi\u0107 \u0160, Velchev V, Michaloliakos I, Jansa P,\u00a0 Mellemkj\u00e6r S, Hassan A,\u00a0 Anton L,\u00a0 Pentik\u00e4inen M,\u00a0 Meneveau N,\u00a0 Tsverava M,\u00a0 Lankeit M, Manginas A, Hizoh I, Maher V,\u00a0 Hirsch,\u00a0 Mukarov MA,\u00a0 Ibrahimi P,\u00a0 Talant S, Rudzitis A, Kiwan G, Gumbien\u0117 L,\u00a0 Codreanu A, Micallef J, Vataman E, Bulatovic N, Chraibi S, Post MC,\u00a0 Kostovska ES,\u00a0 Andreassen AK, Kurzyna M,\u00a0 Pl\u00e1cido R, Coman IM, Vasiltseva O,\u00a0 Zavatta M, \u0160imkova I, Poglajen G,\u00a0 L\u00e1zaro Salvador M, S\u00f6derberg S, Marjeh MYB,\u00a0 Ouarda F,\u00a0 Mutlu B, Sirenko Y, Coghlan JG, Abdullaev T, Baigent C,\u00a0 Antoniou S, Arbelo E,\u00a0 Baumbach A, Borger MA, Collet JP,\u00a0 Gale CP, Halvorsen S,\u00a0 Iung B, Landmesser U, Sitges M, Morgan RL, Sivakumaran K. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237.","DOI":"10.1093\/eurheartj\/ehac237"},{"key":"2095_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.01913-2018.","journal-title":"Eur Respir J"},{"key":"2095_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13071773","author":"M Shafeghat","year":"2025","unstructured":"Shafeghat M, Raza Y, Catania R, Rahsepar AA, Tilkens B, Cuttica MJ, et al. State of the art in pulmonary arterial hypertension: molecular basis, imaging modalities, and right heart failure treatment. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13071773.","journal-title":"Biomedicines"},{"key":"2095_CR6","doi-asserted-by":"publisher","DOI":"10.2174\/0118743064344024250203101417","volume":"19","author":"V Paudyal","year":"2025","unstructured":"Paudyal V, Thapa R, Basnet S, Sharma M, Surani S, Varon J. Updates on pulmonary hypertension. Open Respir Med J. 2025;19:e18743064344024. https:\/\/doi.org\/10.2174\/0118743064344024250203101417.","journal-title":"Open Respir Med J"},{"key":"2095_CR7","first-page":"593","volume":"112","author":"SP Rivers","year":"1992","unstructured":"Rivers SP, Scher LA, Veith FJ. Correction of steal syndrome secondary to hemodialysis access fistulas: a simplified quantitative technique. Surgery. 1992;112:593\u20137.","journal-title":"Surgery"},{"key":"2095_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","volume":"4","author":"MM Hoeper","year":"2016","unstructured":"Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-Hahnle K, et al. A global view of pulmonary hypertension. Lancet Respir Med. 2016;4:306\u201322. https:\/\/doi.org\/10.1016\/S2213-2600(15)00543-3.","journal-title":"Lancet Respir Med"},{"key":"2095_CR9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01899-2018","author":"NW Morrell","year":"2019","unstructured":"Morrell NW, Aldred MA, Chung WK, Elliott CG, Nichols WC, Soubrier F, et al. Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.01899-2018.","journal-title":"Eur Respir J"},{"key":"2095_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.767002","volume":"12","author":"A Tettey","year":"2021","unstructured":"Tettey A, Jiang Y, Li X, Li Y. Therapy for pulmonary arterial hypertension: glance on nitric oxide pathway. Front Pharmacol. 2021;12:767002. https:\/\/doi.org\/10.3389\/fphar.2021.767002.","journal-title":"Front Pharmacol"},{"key":"2095_CR11","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.14336\/AD.2020.0111","volume":"11","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Chen P-P, Zhou R-L, Zhang Y, Tian Z, Zhang S-Y. Pathological mechanisms and potential therapeutic targets of pulmonary arterial hypertension: a review. Aging Dis. 2020;11:1623\u201339. https:\/\/doi.org\/10.14336\/AD.2020.0111.","journal-title":"Aging Dis"},{"key":"2095_CR12","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","volume":"388","author":"MM Hoeper","year":"2023","unstructured":"Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, et al. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388:1478\u201390. https:\/\/doi.org\/10.1056\/NEJMoa2213558.","journal-title":"N Engl J Med"},{"key":"2095_CR13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","volume":"384","author":"M Humbert","year":"2021","unstructured":"Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, et al. Sotatercept for the treatment of pulmonary arterial hypertension. N Engl J Med. 2021;384:1204\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2024277.","journal-title":"N Engl J Med"},{"key":"2095_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature01957","volume":"425","author":"Y Lee","year":"2003","unstructured":"Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415\u20139. https:\/\/doi.org\/10.1038\/nature01957.","journal-title":"Nature"},{"key":"2095_CR15","doi-asserted-by":"publisher","first-page":"E1881","DOI":"10.1073\/pnas.1602532113","volume":"113","author":"Y-K Kim","year":"2016","unstructured":"Kim Y-K, Kim B, Kim VN. Re-evaluation of the roles of DROSHA, export in 5, and DICER in microRNA biogenesis. Proc Natl Acad Sci U S A. 2016;113:E1881-9. https:\/\/doi.org\/10.1073\/pnas.1602532113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2095_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397. https:\/\/doi.org\/10.1016\/s0092-8674(04)00045-5.","journal-title":"Cell"},{"key":"2095_CR17","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513\u20138. https:\/\/doi.org\/10.1073\/pnas.0804549105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2095_CR18","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1093\/nar\/gkr254","volume":"39","author":"A Turchinovich","year":"2011","unstructured":"Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microrna. Nucleic Acids Res. 2011;39:7223\u201333. https:\/\/doi.org\/10.1093\/nar\/gkr254.","journal-title":"Nucleic Acids Res"},{"key":"2095_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstr\u00f6m K, Bossios A, Sj\u00f6strand M, Lee JJ, L\u00f6tvall JO. Exosome-mediated transfer of mrnas and micrornas is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654\u20139. https:\/\/doi.org\/10.1038\/ncb1596.","journal-title":"Nat Cell Biol"},{"key":"2095_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nri2567","volume":"9","author":"C Th\u00e9ry","year":"2009","unstructured":"Th\u00e9ry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581\u201393. https:\/\/doi.org\/10.1038\/nri2567.","journal-title":"Nat Rev Immunol"},{"key":"2095_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.7150\/ijbs.53671","volume":"17","author":"H Wei","year":"2021","unstructured":"Wei H, Chen Q, Lin L, Sha C, Li T, Liu Y, et al. Regulation of exosome production and cargo sorting. Int J Biol Sci. 2021;17:163\u201377. https:\/\/doi.org\/10.7150\/ijbs.53671.","journal-title":"Int J Biol Sci"},{"key":"2095_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000001198","volume":"9","author":"JT DaCunza","year":"2024","unstructured":"DaCunza JT, Wickman JR, Ajit SK. Mirna packaging into small extracellular vesicles and implications in pain. Pain Rep. 2024;9:e1198. https:\/\/doi.org\/10.1097\/PR9.0000000000001198.","journal-title":"Pain Rep"},{"key":"2095_CR23","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","volume":"56","author":"YJ Lee","year":"2024","unstructured":"Lee YJ, Shin KJ, Chae YC. Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med. 2024;56:877\u201389. https:\/\/doi.org\/10.1038\/s12276-024-01209-y.","journal-title":"Exp Mol Med"},{"key":"2095_CR24","doi-asserted-by":"publisher","DOI":"10.1042\/NS20170112","volume":"1","author":"H Scott","year":"2017","unstructured":"Scott H. Extracellular micrornas as messengers in the central and peripheral nervous system. Neuronal Signal. 2017;1:NS20170112. https:\/\/doi.org\/10.1042\/NS20170112.","journal-title":"Neuronal Signal"},{"key":"2095_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41580-023-00576-0","volume":"24","author":"AC Dixson","year":"2023","unstructured":"Dixson AC, Dawson TR, Di Vizio D, Weaver AM. Context-specific regulation of extracellular vesicle biogenesis and cargo selection. Nat Rev Mol Cell Biol. 2023;24:454\u201376. https:\/\/doi.org\/10.1038\/s41580-023-00576-0.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2095_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2024.102206","volume":"105","author":"X-M Liu","year":"2025","unstructured":"Liu X-M, Halushka MK. Beyond the bubble: a debate on microrna sorting into extracellular vesicles. Lab Invest. 2025;105:102206. https:\/\/doi.org\/10.1016\/j.labinv.2024.102206.","journal-title":"Lab Invest"},{"key":"2095_CR27","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.cmet.2021.08.006","volume":"33","author":"R Isaac","year":"2021","unstructured":"Isaac R, Reis FCG, Ying W, Olefsky JM. Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab. 2021;33:1744\u201362. https:\/\/doi.org\/10.1016\/j.cmet.2021.08.006.","journal-title":"Cell Metab"},{"key":"2095_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0362-8","volume":"52","author":"R Kakarla","year":"2020","unstructured":"Kakarla R, Hur J, Kim YJ, Kim J, Chwae Y-J. Apoptotic cell-derived exosomes: messages from dying cells. Exp Mol Med. 2020;52:1\u20136. https:\/\/doi.org\/10.1038\/s12276-019-0362-8.","journal-title":"Exp Mol Med"},{"key":"2095_CR29","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"JD Arroyo","year":"2011","unstructured":"Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003\u20138. https:\/\/doi.org\/10.1073\/pnas.1019055108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2095_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.01088","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang L, Ding H, Zhang Y, Wang Y, Zhu W, Li P. Circulating micrornas: biogenesis and clinical significance in acute myocardial infarction. Front Physiol. 2020;11:1088. https:\/\/doi.org\/10.3389\/fphys.2020.01088.","journal-title":"Front Physiol"},{"key":"2095_CR31","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1177\/0271678X241254772","volume":"44","author":"H Sawant","year":"2024","unstructured":"Sawant H, Sun B, Mcgrady E, Bihl JC. Role of mirnas in neurovascular injury and repair. J Cereb Blood Flow Metab. 2024;44:1693\u2013708. https:\/\/doi.org\/10.1177\/0271678X241254772.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2095_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20101812","volume":"208","author":"A Courboulin","year":"2011","unstructured":"Courboulin A, Paulin R, Gigu\u00e8re NJ, Saksouk N, Perreault T, Meloche J, et al. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med. 2011;208:535\u201348. https:\/\/doi.org\/10.1084\/jem.20101812.","journal-title":"J Exp Med"},{"key":"2095_CR33","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1172\/JCI74773","volume":"124","author":"T Bertero","year":"2014","unstructured":"Bertero T, Lu Y, Annis S, Hale A, Bhat B, Saggar R, et al. Systems-level regulation of microrna networks by miR-130\/301 promotes pulmonary hypertension. J Clin Invest. 2014;124:3514\u201328. https:\/\/doi.org\/10.1172\/JCI74773.","journal-title":"J Clin Invest"},{"key":"2095_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1164\/rccm.201205-0839OC","volume":"187","author":"CJ Rhodes","year":"2013","unstructured":"Rhodes CJ, Wharton J, Boon RA, Roexe T, Tsang H, Wojciak-Stothard B, et al. Reduced microrna-150 is associated with poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;187:294\u2013302. https:\/\/doi.org\/10.1164\/rccm.201205-0839OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2095_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-015-0037-0","volume":"3","author":"A Mangolini","year":"2015","unstructured":"Mangolini A, Ferracin M, Zanzi MV, Saccenti E, Ebnaof SO, Poma VV, et al. Diagnostic and prognostic micrornas in the serum of breast cancer patients measured by droplet digital PCR. Biomark Res. 2015;3:12. https:\/\/doi.org\/10.1186\/s40364-015-0037-0.","journal-title":"Biomark Res"},{"key":"2095_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201069","volume":"13","author":"HG Binderup","year":"2018","unstructured":"Binderup HG, Madsen JS, Heegaard NHH, Houlind K, Andersen RF, Brasen CL. Quantification of microrna levels in plasma - impact of preanalytical and analytical conditions. PLoS One. 2018;13:e0201069. https:\/\/doi.org\/10.1371\/journal.pone.0201069.","journal-title":"PLoS One"},{"key":"2095_CR37","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","volume":"59","author":"T Blondal","year":"2013","unstructured":"Blondal T, Nielsen S. Jensby, Baker A, Andreasen D, Mouritzen P, Teilum M. Wrang, et al. Assessing sample and mirna profile quality in serum and plasma or other biofluids. Methods. 2013;59:S1-6. https:\/\/doi.org\/10.1016\/j.ymeth.2012.09.015.","journal-title":"Methods"},{"key":"2095_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","volume":"5","author":"CC Pritchard","year":"2012","unstructured":"Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, et al. Blood cell origin of circulating micrornas: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila). 2012;5:492\u20137. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-11-0370.","journal-title":"Cancer Prev Res (Phila)"},{"key":"2095_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-6-r64","volume":"10","author":"P Mestdagh","year":"2009","unstructured":"Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, et al. A novel and universal method for microrna RT-qPCR data normalization. Genome Biol. 2009;10:R64. https:\/\/doi.org\/10.1186\/gb-2009-10-6-r64.","journal-title":"Genome Biol"},{"key":"2095_CR40","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrg3198","volume":"13","author":"CC Pritchard","year":"2012","unstructured":"Pritchard CC, Cheng HH, Tewari M. Microrna profiling: approaches and considerations. Nat Rev Genet. 2012;13:358\u201369. https:\/\/doi.org\/10.1038\/nrg3198.","journal-title":"Nat Rev Genet"},{"key":"2095_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024145","volume":"6","author":"MB Kirschner","year":"2011","unstructured":"Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, et al. Haemolysis during sample preparation alters microrna content of plasma. PLoS One. 2011;6:e24145. https:\/\/doi.org\/10.1371\/journal.pone.0024145.","journal-title":"PLoS One"},{"key":"2095_CR42","doi-asserted-by":"publisher","DOI":"10.52225\/narra.v4i1.579","volume":"4","author":"FM Siregar","year":"2024","unstructured":"Siregar FM, Hartopo AB, Haryana SM. Recent progress in the roles of micrornas in pulmonary arterial hypertension associated with congenital heart disease. Narra J. 2024;4:e579. https:\/\/doi.org\/10.52225\/narra.v4i1.579.","journal-title":"Narra J"},{"key":"2095_CR43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.124.004862","volume":"18","author":"N Errington","year":"2025","unstructured":"Errington N, Zhou L, Rhodes CJ, Fong Y-L, Zhou L, Kariotis S, Harder E, Waxman A, Jatkoe T, Wharton J, Thompson AAR, Condliffe RA, Kiely DG, Howard LS, Toshner M, He C, Wang D, Wilkins MR, Lawrie A. Diagnostic microrna signatures to support classification of pulmonary hypertension. Circ: Genom Precis Med. 2025;18: e004862. https:\/\/doi.org\/10.1161\/CIRCGEN.124.004862.","journal-title":"Circ: Genom Precis Med"},{"key":"2095_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031435","volume":"12","author":"W-T Chang","year":"2023","unstructured":"Chang W-T, Lee W-C, Lin Y-W, Shih J-Y, Hong C-S, Chen Z-C, et al. Transpulmonary expression of exosomal micrornas in idiopathic and congenital heart disease-related pulmonary arterial hypertension. J Am Heart Assoc. 2023;12:e031435. https:\/\/doi.org\/10.1161\/JAHA.123.031435.","journal-title":"J Am Heart Assoc"},{"key":"2095_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s43044-023-00395-w","volume":"75","author":"MO Dimitry","year":"2023","unstructured":"Dimitry MO, Soliman YMA, ElKorashy RI, Raslan HM, Kamel SA, Hassan EM, et al. Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension. Egypt Heart J. 2023;75:76. https:\/\/doi.org\/10.1186\/s43044-023-00395-w.","journal-title":"Egypt Heart J"},{"key":"2095_CR46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/ame2.12253","volume":"5","author":"X Hu","year":"2022","unstructured":"Hu X, Wang Q, Zhao H, Wu W, Zhao Q, Jiang R, et al. Role of miR-21-5p\/FilGAP axis in estradiol alleviating the progression of monocrotaline-induced pulmonary hypertension. Anim Models Exp Med. 2022;5:217\u201326. https:\/\/doi.org\/10.1002\/ame2.12253.","journal-title":"Anim Models Exp Med"},{"key":"2095_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030564","author":"W-T Chang","year":"2022","unstructured":"Chang W-T, Wu C-C, Lin Y-W, Shih J-Y, Chen Z-C, Wu S-N, et al. Dynamic changes in miR-21 regulate right ventricular dysfunction in congenital heart disease-related pulmonary arterial hypertension. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11030564.","journal-title":"Cells"},{"key":"2095_CR48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/QAI.0000000000000741","volume":"70","author":"VN Parikh","year":"2015","unstructured":"Parikh VN, Park J, Nikolic I, Channick R, Yu PB, De Marco T, et al. Coordinated modulation of circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV\/Hepatitis C Virus Coinfection. J Acquir Immune Defic Syndr. 2015;70:236\u201341. https:\/\/doi.org\/10.1097\/QAI.0000000000000741.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2095_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1596767","volume":"16","author":"Y Huang","year":"2025","unstructured":"Huang Y, Ma W, Guo C, Su X. Mechanism of action and potential therapeutic targets of TGF-\u03b2-related signaling pathway and its downstream miRNA expression in pulmonary arterial hypertension. Front Pharmacol. 2025;16:1596767. https:\/\/doi.org\/10.3389\/fphar.2025.1596767.","journal-title":"Front Pharmacol"},{"key":"2095_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/toxics12060396","volume":"12","author":"B He","year":"2024","unstructured":"He B, Shao B, Cheng C, Ye Z, Yang Y, Fan B, et al. MiR-21-mediated endothelial senescence and dysfunction are involved in cigarette smoke-induced pulmonary hypertension through activation of PI3K\/AKT\/mTOR signaling. Toxics. 2024;12:10.3390\/toxics12060396.","journal-title":"Toxics"},{"key":"2095_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1042\/BJ20140486","volume":"462","author":"L Iannone","year":"2014","unstructured":"Iannone L, Zhao L, Dubois O, Duluc L, Rhodes CJ, Wharton J, et al. miR-21\/DDAH1 pathway regulates pulmonary vascular responses to hypoxia. Biochem J. 2014;462:103\u201312. https:\/\/doi.org\/10.1042\/BJ20140486.","journal-title":"Biochem J"},{"key":"2095_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175725","volume":"949","author":"P Liu","year":"2023","unstructured":"Liu P, Gao S, Li Z, Pan S, Luo G, Ji Z. Endothelial progenitor cell-derived exosomes inhibit pulmonary artery smooth muscle cell in vitro proliferation and resistance to apoptosis by modulating the Mitofusin-2 and Ras-Raf-ERK1\/2 signaling pathway. Eur J Pharmacol. 2023;949:175725. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175725.","journal-title":"Eur J Pharmacol"},{"key":"2095_CR53","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.113.03037","volume":"64","author":"K White","year":"2014","unstructured":"White K, Dempsie Y, Caruso P, Wallace E, McDonald RA, Stevens H, et al. Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA\/programmed cell death 4\/caspase-3 axis. Hypertension. 2014;64:185\u201394. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.03037.","journal-title":"Hypertension"},{"key":"2095_CR54","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1159\/000495243","volume":"51","author":"F Li","year":"2018","unstructured":"Li F, Wang J, Zhu Y, Liu L, Feng W, Shi W, et al. SphK1\/S1P mediates PDGF-induced pulmonary arterial smooth muscle cell proliferation via miR-21\/BMPRII\/Id1 signaling pathway. Cell Physiol Biochem. 2018;51:487\u2013500. https:\/\/doi.org\/10.1159\/000495243.","journal-title":"Cell Physiol Biochem"},{"key":"2095_CR55","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/PCC.0000000000002207","volume":"21","author":"P Chouvarine","year":"2020","unstructured":"Chouvarine P, Geldner J, Giagnorio R, Legchenko E, Bertram H, Hansmann G. Trans-right-ventricle and transpulmonary microrna gradients in human pulmonary arterial hypertension. Pediatr Crit Care Med. 2020;21:340\u20139. https:\/\/doi.org\/10.1097\/PCC.0000000000002207.","journal-title":"Pediatr Crit Care Med"},{"key":"2095_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.980718","volume":"9","author":"S Rogula","year":"2022","unstructured":"Rogula S, Pomirski B, Czy\u017cak N, Eyileten C, Postu\u0142a M, Szarpak \u0141, et al. Biomarker-based approach to determine etiology and severity of pulmonary hypertension: focus on microRNA. Front Cardiovasc Med. 2022;9:980718. https:\/\/doi.org\/10.3389\/fcvm.2022.980718.","journal-title":"Front Cardiovasc Med"},{"key":"2095_CR57","first-page":"5703","volume":"10","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Zhou Y. Circulating miR-21 and miR-423-5p as biomarkers for heart failure in heart valve disease patients. Int J Clin Exp Pathol. 2017;10:5703\u201311.","journal-title":"Int J Clin Exp Pathol"},{"key":"2095_CR58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nm.3040","volume":"19","author":"J Kim","year":"2013","unstructured":"Kim J, Kang Y, Kojima Y, Lighthouse JK, Hu X, Aldred MA, et al. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med. 2013;19:74\u201382. https:\/\/doi.org\/10.1038\/nm.3040.","journal-title":"Nat Med"},{"key":"2095_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cvr\/cvx187","volume":"114","author":"R Baptista","year":"2018","unstructured":"Baptista R, Marques C, Catarino S, Enguita FJ, Costa MC, Matafome P, et al. Microrna-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1. Cardiovasc Res. 2018;114:53\u201364. https:\/\/doi.org\/10.1093\/cvr\/cvx187.","journal-title":"Cardiovasc Res"},{"key":"2095_CR60","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1159\/000373970","volume":"35","author":"Y-S Wang","year":"2015","unstructured":"Wang Y-S, Zhou J, Hong K, Cheng X-S, Li Y-G. Microrna-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase. Cell Physiol Biochem. 2015;35:1546\u201356. https:\/\/doi.org\/10.1159\/000373970.","journal-title":"Cell Physiol Biochem"},{"key":"2095_CR61","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1158\/1078-0432.CCR-13-0601","volume":"19","author":"MM Streppel","year":"2013","unstructured":"Streppel MM, Pai S, Campbell NR, Hu C, Yabuuchi S, Canto MI, et al. Microrna 223 is upregulated in the multistep progression of Barrett\u2019s esophagus and modulates sensitivity to chemotherapy by targeting PARP1. Clin Cancer Res. 2013;19:4067\u201378. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0601.","journal-title":"Clin Cancer Res"},{"key":"2095_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/srep24900","volume":"6","author":"Y Zeng","year":"2016","unstructured":"Zeng Y, Zhang X, Kang K, Chen J, Wu Z, Huang J, et al. MicroRNA-223 attenuates hypoxia-induced vascular remodeling by targeting RhoB\/MLC2 in pulmonary arterial smooth muscle cells. Sci Rep. 2016;6:24900. https:\/\/doi.org\/10.1038\/srep24900.","journal-title":"Sci Rep"},{"key":"2095_CR63","doi-asserted-by":"publisher","first-page":"C363","DOI":"10.1152\/ajpcell.00149.2015","volume":"309","author":"J Meloche","year":"2015","unstructured":"Meloche J, Le Guen M, Potus F, Vinck J, Ranchoux B, Johnson I, et al. MiR-223 reverses experimental pulmonary arterial hypertension. Am J Physiol Cell Physiol. 2015;309:C363-72. https:\/\/doi.org\/10.1152\/ajpcell.00149.2015.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2095_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118420","volume":"262","author":"J Guo","year":"2020","unstructured":"Guo J, Zhang L, Lian L, Hao M, Chen S, Hong Y. CircATP2B4 promotes hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells via the miR-223\/ATR axis. Life Sci. 2020;262:118420. https:\/\/doi.org\/10.1016\/j.lfs.2020.118420.","journal-title":"Life Sci"},{"key":"2095_CR65","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4239\/wjd.v14.i2.110","volume":"14","author":"D-D Xue","year":"2023","unstructured":"Xue D-D, Zhang X, Li D-W, Yang Y-L, Liu J-J. Protective effect of liraglutide on the myocardium of type 2 diabetic rats by inhibiting polyadenosine diphosphate-ribose polymerase-1. World J Diabetes. 2023;14:110\u20139. https:\/\/doi.org\/10.4239\/wjd.v14.i2.110.","journal-title":"World J Diabetes"},{"key":"2095_CR66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2147\/PGPM.S39765","volume":"7","author":"MW Audeh","year":"2014","unstructured":"Audeh MW. Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition. Pharmacogenomics Pers Med. 2014;7:307\u201316. https:\/\/doi.org\/10.2147\/PGPM.S39765.","journal-title":"Pharmacogenomics Pers Med"},{"key":"2095_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12253-008-9086-0","volume":"15","author":"B Csete","year":"2009","unstructured":"Csete B, Lengyel Z, K\u00e1d\u00e1r Z, Batty\u00e1ni Z. Poly(adenosine diphosphate-ribose) polymerase-1 expression in cutaneous malignant melanomas as a new molecular marker of aggressive tumor. Pathol Oncol Res. 2009;15:47\u201353. https:\/\/doi.org\/10.1007\/s12253-008-9086-0.","journal-title":"Pathol Oncol Res"},{"key":"2095_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147827","volume":"11","author":"IB Gubrij","year":"2016","unstructured":"Gubrij IB, Pangle AK, Pang L, Johnson LG. Reversal of MicroRNA dysregulation in an animal model of pulmonary hypertension. PLoS One. 2016;11:e0147827. https:\/\/doi.org\/10.1371\/journal.pone.0147827.","journal-title":"PLoS One"},{"key":"2095_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12550","volume":"52","author":"A Liu","year":"2019","unstructured":"Liu A, Liu Y, Li B, Yang M, Liu Y, Su J. Role of miR-223-3p in pulmonary arterial hypertension via targeting ITGB3 in the ECM pathway. Cell Prolif. 2019;52:e12550. https:\/\/doi.org\/10.1111\/cpr.12550.","journal-title":"Cell Prolif"},{"key":"2095_CR70","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/cvr\/cvw065","volume":"111","author":"L Shi","year":"2016","unstructured":"Shi L, Kojonazarov B, Elgheznawy A, Popp R, Dahal BK, B\u00f6hm M, et al. MiR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach. Cardiovasc Res. 2016;111:184\u201393. https:\/\/doi.org\/10.1093\/cvr\/cvw065.","journal-title":"Cardiovasc Res"},{"key":"2095_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103444","volume":"69","author":"N Errington","year":"2021","unstructured":"Errington N, Iremonger J, Pickworth JA, Kariotis S, Rhodes CJ, Rothman AM, et al. A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach. EBioMedicine. 2021;69:103444. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103444.","journal-title":"EBioMedicine"},{"key":"2095_CR72","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/HYPERTENSIONAHA.121.14536","volume":"78","author":"J Liu","year":"2021","unstructured":"Liu J, Liu Y, Wang F, Liang M. MiR-204: molecular regulation and role in cardiovascular and renal diseases. Hypertension. 2021;78:270\u201381. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.14536.","journal-title":"Hypertension"},{"key":"2095_CR73","doi-asserted-by":"publisher","first-page":"130","DOI":"10.55730\/1300-0144.5566","volume":"53","author":"Z D\u00fczg\u00fcn","year":"2023","unstructured":"D\u00fczg\u00fcn Z, Kay\u0131k\u00e7\u0131o\u011flu LM, Aktan \u00c7, Bara B, Ero\u011flu FZ, Ya\u011fmur B, et al. Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension. Turk J Med Sci. 2023;53:130\u201341. https:\/\/doi.org\/10.55730\/1300-0144.5566.","journal-title":"Turk J Med Sci"},{"key":"2095_CR74","doi-asserted-by":"publisher","first-page":"764","DOI":"10.22038\/AJP.2024.24522","volume":"14","author":"Z Kordestani","year":"2024","unstructured":"Kordestani Z, Beik A, Najafipour H, Safi Z, Askaripour M, Rajabi S. Perillyl alcohol, quercetin, and berberine combination therapy ameliorates experimental pulmonary arterial hypertension: effects on the lung miR-204 expression, remodeling, and inflammatory factors. Avicenna J Phytomed. 2024;14:764\u201375. https:\/\/doi.org\/10.22038\/AJP.2024.24522.","journal-title":"Avicenna J Phytomed"},{"key":"2095_CR75","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/FJC.0000000000001015","volume":"77","author":"S Rajabi","year":"2021","unstructured":"Rajabi S, Najafipour H, Jafarinejad-Farsangi S, Joukar S, Beik A, Askaripour M, et al. Quercetin, perillyl alcohol, and berberine ameliorate right ventricular disorders in experimental pulmonary arterial hypertension: effects on miR-204, miR-27a, fibrotic, apoptotic, and inflammatory factors. J Cardiovasc Pharmacol. 2021;77:777\u201386. https:\/\/doi.org\/10.1097\/FJC.0000000000001015.","journal-title":"J Cardiovasc Pharmacol"},{"key":"2095_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-020-03015-1","volume":"20","author":"S Rajabi","year":"2020","unstructured":"Rajabi S, Najafipour H, Jafarinejad Farsangi S, Joukar S, Beik A, Iranpour M, et al. Perillyle alcohol and quercetin ameliorate monocrotaline-induced pulmonary artery hypertension in rats through PARP1-mediated miR-204 down-regulation and its downstream pathway. BMC Complement Med Ther. 2020;20:218. https:\/\/doi.org\/10.1186\/s12906-020-03015-1.","journal-title":"BMC Complement Med Ther"},{"key":"2095_CR77","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1164\/rccm.201604-0886PP","volume":"195","author":"HJ Chun","year":"2017","unstructured":"Chun HJ, Bonnet S, Chan SY. Translational advances in the field of pulmonary hypertension. Translating MicroRNA biology in pulmonary hypertension. It will take more than \u201cmiR\u201d words. Am J Respir Crit Care Med. 2017;195:167\u201378. https:\/\/doi.org\/10.1164\/rccm.201604-0886PP.","journal-title":"Am J Respir Crit Care Med"},{"key":"2095_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172673","volume":"863","author":"T Liu","year":"2019","unstructured":"Liu T, Zou X-Z, Huang N, Ge X-Y, Yao M-Z, Liu H, et al. Down-regulation of miR-204 attenuates endothelial-mesenchymal transition by enhancing autophagy in hypoxia-induced pulmonary hypertension. Eur J Pharmacol. 2019;863:172673. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172673.","journal-title":"Eur J Pharmacol"},{"key":"2095_CR79","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00109-017-1619-0","volume":"96","author":"A Bourgeois","year":"2018","unstructured":"Bourgeois A, Lambert C, Habbout K, Ranchoux B, Paquet-Marceau S, Trinh I, et al. FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension. J Mol Med (Berl). 2018;96:223\u201335. https:\/\/doi.org\/10.1007\/s00109-017-1619-0.","journal-title":"J Mol Med (Berl)"},{"key":"2095_CR80","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.yexcr.2017.11.032","volume":"362","author":"H Yu","year":"2018","unstructured":"Yu H, Xu M, Dong Y, Liu J, Li Y, Mao W, et al. 1,25(OH)2D3 attenuates pulmonary arterial hypertension via microRNA-204 mediated Tgfbr2\/Smad signaling. Exp Cell Res. 2018;362:311\u201323. https:\/\/doi.org\/10.1016\/j.yexcr.2017.11.032.","journal-title":"Exp Cell Res"},{"key":"2095_CR81","doi-asserted-by":"publisher","first-page":"10173","DOI":"10.12659\/MSM.917662","volume":"25","author":"X Li","year":"2019","unstructured":"Li X, Xiang D, Shu Y, Hu K, Zhang Y, Li Y. Microrna-204 as an indicator of severity of pulmonary hypertension in children with congenital heart disease complicated with pulmonary hypertension. Med Sci Monit. 2019;25:10173\u20139. https:\/\/doi.org\/10.12659\/MSM.917662.","journal-title":"Med Sci Monit"},{"key":"2095_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s43168-024-00288-9","volume":"18","author":"MO Dimitry","year":"2024","unstructured":"Dimitry MO, Amin YM, ElKorashy RI, Raslan HM, Kamel SA, Hassan EM, et al. Role and predictive value of microRNAs 204 and 210 in the diagnosis of pulmonary arterial hypertension and the distinction between idiopathic, systemic sclerosis, and schistosomiasis-associated pulmonary arterial hypertension. Egypt J Bronchol. 2024;18:37. https:\/\/doi.org\/10.1186\/s43168-024-00288-9.","journal-title":"Egypt J Bronchol"},{"key":"2095_CR83","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1161\/CIRCRESAHA.112.267591","volume":"111","author":"P Caruso","year":"2012","unstructured":"Caruso P, Dempsie Y, Stevens HC, McDonald RA, Long L, Lu R, et al. A role for mir-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ Res. 2012;111:290\u2013300. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.267591.","journal-title":"Circ Res"},{"key":"2095_CR84","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/CIRCRESAHA.115.306806","volume":"117","author":"L Deng","year":"2015","unstructured":"Deng L, Blanco FJ, Stevens H, Lu R, Caudrillier A, McBride M, et al. Microrna-143 activation regulates smooth muscle and endothelial cell crosstalk in pulmonary arterial hypertension. Circ Res. 2015;117:870\u201383. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306806.","journal-title":"Circ Res"},{"key":"2095_CR85","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1097\/CM9.0000000000001193","volume":"133","author":"Y-Z Zhang","year":"2020","unstructured":"Zhang Y-Z, Li G, Yan D-L, Liu Y-L. Microrna-98 can serve as a diagnostic marker for congenital heart disease-associated pulmonary artery hypertension. Chin Med J (Engl). 2020;133:3007\u20139. https:\/\/doi.org\/10.1097\/CM9.0000000000001193.","journal-title":"Chin Med J (Engl)"},{"key":"2095_CR86","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1165\/rcmb.2014-0337OC","volume":"54","author":"B-Y Kang","year":"2016","unstructured":"Kang B-Y, Park KK, Kleinhenz JM, Murphy TC, Green DE, Bijli KM, et al. Peroxisome proliferator-activated receptor \u03b3 and microrna 98 in hypoxia-induced endothelin-1 signaling. Am J Respir Cell Mol Biol. 2016;54:136\u201346. https:\/\/doi.org\/10.1165\/rcmb.2014-0337OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2095_CR87","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.26355\/eurrev_201904_17588","volume":"23","author":"Y Yuan","year":"2019","unstructured":"Yuan Y, Shen C, Zhao S-L, Hu Y-J, Song Y, Zhong Q-J. Microrna-126 affects cell apoptosis, proliferation, cell cycle and modulates VEGF\/TGF-\u03b2 levels in pulmonary artery endothelial cells. Eur Rev Med Pharmacol Sci. 2019;23:3058\u201369. https:\/\/doi.org\/10.26355\/eurrev_201904_17588.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2095_CR88","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.115.016382","volume":"132","author":"F Potus","year":"2015","unstructured":"Potus F, Ruffenach G, Dahou A, Thebault C, Breuils-Bonnet S, Tremblay \u00c8, et al. Downregulation of microrna-126 contributes to the failing right ventricle in pulmonary arterial hypertension. Circulation. 2015;132:932\u201343. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016382.","journal-title":"Circulation"},{"key":"2095_CR89","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1086\/675980","volume":"4","author":"F Potus","year":"2014","unstructured":"Potus F, Graydon C, Provencher S, Bonnet S. Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series). Pulm Circ. 2014;4:175\u201384. https:\/\/doi.org\/10.1086\/675980.","journal-title":"Pulm Circ"},{"key":"2095_CR90","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.healun.2012.03.010","volume":"31","author":"CL Bockmeyer","year":"2012","unstructured":"Bockmeyer CL, Maegel L, Janciauskiene S, Rische J, Lehmann U, Maus UA, et al. Plexiform vasculopathy of severe pulmonary arterial hypertension and microRNA expression. J Heart Lung Transplant. 2012;31:764\u201372. https:\/\/doi.org\/10.1016\/j.healun.2012.03.010.","journal-title":"J Heart Lung Transplant"},{"key":"2095_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158054","author":"J Santos-Gomes","year":"2024","unstructured":"Santos-Gomes J, Mendes-Ferreira P, Ad\u00e3o R, Maia-Rocha C, Rego B, Poels M, et al. Unraveling the impact of miR-146a in pulmonary arterial hypertension pathophysiology and right ventricular function. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25158054.","journal-title":"Int J Mol Sci"},{"key":"2095_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064396","volume":"8","author":"C Wei","year":"2013","unstructured":"Wei C, Henderson H, Spradley C, Li L, Kim I-K, Kumar S, et al. Circulating miRNAs as potential marker for pulmonary hypertension. PLoS One. 2013;8:e64396. https:\/\/doi.org\/10.1371\/journal.pone.0064396.","journal-title":"PLoS One"},{"key":"2095_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70528","volume":"29","author":"M Cabiati","year":"2025","unstructured":"Cabiati M, Biondi F, Ghelardoni S, Casieri V, Lionetti V, Sgalippa A, et al. Ambrisentan retains its pro-autophagic activity on human pulmonary artery endothelial cells exposed to hypoxia in an in\u00a0vitro model mimicking diabetes. J Cell Mol Med. 2025;29:e70528. https:\/\/doi.org\/10.1111\/jcmm.70528.","journal-title":"J Cell Mol Med"},{"key":"2095_CR94","doi-asserted-by":"publisher","DOI":"10.1177\/2045894020974919","volume":"10","author":"Z Wu","year":"2020","unstructured":"Wu Z, Geng J, Qi Y, Li J, Bai Y, Guo Z. MiR-193-3p attenuates the vascular remodeling in pulmonary arterial hypertension by targeting PAK4. Pulm Circ. 2020;10:2045894020974919. https:\/\/doi.org\/10.1177\/2045894020974919.","journal-title":"Pulm Circ"},{"key":"2095_CR95","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/CIRCULATIONAHA.114.007405","volume":"130","author":"S Sharma","year":"2014","unstructured":"Sharma S, Umar S, Potus F, Iorga A, Wong G, Meriwether D, et al. Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p. Circulation. 2014;130:776\u201385. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.007405.","journal-title":"Circulation"},{"key":"2095_CR96","doi-asserted-by":"publisher","unstructured":"Preethi KA, Selvakumar SC, Sekar D. Abstract 11414: Anti-Mir-7110\u20133p as a therapeutic molecule in monocrotaline induced pulmonary arterial hypertension rat model. Circulation. 2022;146. https:\/\/doi.org\/10.1161\/circ.146.suppl_1.11414.","DOI":"10.1161\/circ.146.suppl_1.11414"},{"key":"2095_CR97","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jash.2014.12.011","volume":"9","author":"J Bienertova-Vasku","year":"2015","unstructured":"Bienertova-Vasku J, Novak J, Vasku A. MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment. J Am Soc Hypertens. 2015;9:221\u201334. https:\/\/doi.org\/10.1016\/j.jash.2014.12.011.","journal-title":"J Am Soc Hypertens"},{"key":"2095_CR98","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/CIRCRESAHA.114.301633","volume":"114","author":"D Wang","year":"2014","unstructured":"Wang D, Zhang H, Li M, Frid MG, Flockton AR, McKeon BA, et al. Microrna-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts. Circ Res. 2014;114:67\u201378. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.301633.","journal-title":"Circ Res"},{"key":"2095_CR99","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.117.028034","volume":"136","author":"P Caruso","year":"2017","unstructured":"Caruso P, Dunmore BJ, Schlosser K, Schoors S, Dos Santos C, Perez-Iratxeta C, et al. Identification of MicroRNA-124 as a major regulator of enhanced endothelial cell glycolysis in pulmonary arterial hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2. Circulation. 2017;136:2451\u201367. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028034.","journal-title":"Circulation"},{"key":"2095_CR100","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1161\/CIRCULATIONAHA.117.028069","volume":"136","author":"H Zhang","year":"2017","unstructured":"Zhang H, Wang D, Li M, Plecit\u00e1-Hlavat\u00e1 L, D\u2019Alessandro A, Tauber J, et al. Metabolic and proliferative state of vascular adventitial fibroblasts in pulmonary hypertension is regulated through a MicroRNA-124\/PTBP1 (Polypyrimidine Tract Binding Protein 1)\/Pyruvate Kinase Muscle axis. Circulation. 2017;136:2468\u201385. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028069.","journal-title":"Circulation"},{"key":"2095_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2021.115599","volume":"425","author":"M Jasi\u0144ska-Stroschein","year":"2021","unstructured":"Jasi\u0144ska-Stroschein M. A review of rodent models for metabolic syndromes and pulmonary hypertension. Toxicol Appl Pharmacol. 2021;425:115599. https:\/\/doi.org\/10.1016\/j.taap.2021.115599.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2095_CR102","doi-asserted-by":"publisher","first-page":"25414","DOI":"10.1074\/jbc.M113.460287","volume":"288","author":"K Kang","year":"2013","unstructured":"Kang K, Peng X, Zhang X, Wang Y, Zhang L, Gao L, et al. Microrna-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells. J Biol Chem. 2013;288:25414\u201327. https:\/\/doi.org\/10.1074\/jbc.M113.460287.","journal-title":"J Biol Chem"},{"key":"2095_CR103","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.healun.2019.09.010","volume":"38","author":"VV McLaughlin","year":"2019","unstructured":"McLaughlin VV, Vachiery J-L, Oudiz RJ, Rosenkranz S, Gali\u00e8 N, Barber\u00e0 JA, et al. Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: results from the AMBITION trial. J Heart Lung Transplant. 2019;38:1286\u201395. https:\/\/doi.org\/10.1016\/j.healun.2019.09.010.","journal-title":"J Heart Lung Transplant"},{"key":"2095_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11226671","author":"R Madonna","year":"2022","unstructured":"Madonna R. Pulmonary arterial hypertension in genetic and comorbid settings: a step forward for precision medicine. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11226671.","journal-title":"J Clin Med"},{"key":"2095_CR105","doi-asserted-by":"publisher","first-page":"L861","DOI":"10.1152\/ajplung.00201.2010","volume":"299","author":"J Sarkar","year":"2010","unstructured":"Sarkar J, Gou D, Turaka P, Viktorova E, Ramchandran R, Raj JU. Microrna-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol. 2010;299:L861-71. https:\/\/doi.org\/10.1152\/ajplung.00201.2010.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2095_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01988-0","volume":"22","author":"M Nemecz","year":"2023","unstructured":"Nemecz M, Stefan DS, Comari\u021ba IK, Constantin A, Tanko G, Guja C, et al. Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential. Cardiovasc Diabetol. 2023;22:260. https:\/\/doi.org\/10.1186\/s12933-023-01988-0.","journal-title":"Cardiovasc Diabetol"},{"key":"2095_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011023","author":"K Flores","year":"2024","unstructured":"Flores K, Almeida C, Arriaza K, Pena E, El Alam S. mTOR in the development of hypoxic pulmonary hypertension associated with cardiometabolic risk factors. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms252011023.","journal-title":"Int J Mol Sci"},{"key":"2095_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020542","author":"R B\u0142aszczyk","year":"2024","unstructured":"B\u0142aszczyk R, Petniak A, Bogucki J, Kocki J, Wysoki\u0144ski A, G\u0142owniak A. Association between resistant arterial hypertension, type 2 diabetes, and selected microRNAs. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13020542.","journal-title":"J Clin Med"},{"key":"2095_CR109","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","volume":"107","author":"A Zampetaki","year":"2010","unstructured":"Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107:810\u20137. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.226357.","journal-title":"Circ Res"},{"key":"2095_CR110","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/cvr\/cvaa195","volume":"116","author":"C B\u00e4r","year":"2020","unstructured":"B\u00e4r C, Chatterjee S, Falc\u00e3o Pires I, Rodrigues P, Sluijter JPG, Boon RA, et al. Non-coding RNAs: update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart. Cardiovasc Res. 2020;116:1805\u201319. https:\/\/doi.org\/10.1093\/cvr\/cvaa195.","journal-title":"Cardiovasc Res"},{"key":"2095_CR111","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/cvr\/cvx070","volume":"113","author":"C Perrino","year":"2017","unstructured":"Perrino C, Barab\u00e1si A-L, Condorelli G, Davidson SM, De Windt L, Dimmeler S, et al. Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. Cardiovasc Res. 2017;113:725\u201336. https:\/\/doi.org\/10.1093\/cvr\/cvx070.","journal-title":"Cardiovasc Res"},{"key":"2095_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00478","volume":"10","author":"J Hanna","year":"2019","unstructured":"Hanna J, Hossain GS, Kocerha J. The potential for microRNA therapeutics and clinical research. Front Genet. 2019;10:478. https:\/\/doi.org\/10.3389\/fgene.2019.00478.","journal-title":"Front Genet"},{"key":"2095_CR113","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203\u201322. https:\/\/doi.org\/10.1038\/nrd.2016.246.","journal-title":"Nat Rev Drug Discov"},{"key":"2095_CR114","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1681\/ASN.2019101100","volume":"31","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Wang D, Wang F, Liu J, Huang B, Baker MA, et al. Endogenous miR-204 protects the kidney against chronic injury in hypertension and diabetes. J Am Soc Nephrol. 2020;31:1539\u201354. https:\/\/doi.org\/10.1681\/ASN.2019101100.","journal-title":"J Am Soc Nephrol"},{"key":"2095_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00890","volume":"9","author":"V Segura-Ibarra","year":"2018","unstructured":"Segura-Ibarra V, Wu S, Hassan N, Moran-Guerrero JA, Ferrari M, Guha A, et al. Nanotherapeutics for treatment of pulmonary arterial hypertension. Front Physiol. 2018;9:890. https:\/\/doi.org\/10.3389\/fphys.2018.00890.","journal-title":"Front Physiol"},{"key":"2095_CR116","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ejhf.984","volume":"20","author":"A Bay\u00e9s-Genis","year":"2018","unstructured":"Bay\u00e9s-Genis A, Lanfear DE, de Ron MWJ, Lup\u00f3n J, Leenders JJ, Liu Z, et al. Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients. Eur J Heart Fail. 2018;20:67\u201375. https:\/\/doi.org\/10.1002\/ejhf.984.","journal-title":"Eur J Heart Fail"},{"key":"2095_CR117","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ejhf.950","volume":"20","author":"N van Boven","year":"2018","unstructured":"van Boven N, Kardys I, van Vark LC, Akkerhuis KM, de Ron MWJ, Khan MAF, et al. Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure. Eur J Heart Fail. 2018;20:89\u201396. https:\/\/doi.org\/10.1002\/ejhf.950.","journal-title":"Eur J Heart Fail"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02095-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02095-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02095-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:39:20Z","timestamp":1773049160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02095-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":117,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02095-0","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"\u00a0Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}